Effect of renal microsomes and renal lysosomes on in vitro hepatic fatty acid synthesis.
An inhibitor and stimulator of in vitro hepatic fatty acid synthesis are present in renal microsomes. In addition, a stimulator of fatty acid synthesis is present in renal lysosomes. Renal microsomal inhibition of hepatic fatty acid synthesis is not due to the depletion of cofactors in the system. This inhibitor appears to be located exclusively in the kidney medullary microsomes. It is destroyed by Pronase and heat treatment suggesting it may be a protein. Its effects on fatty acid synthesis may be attributed in part to ATPase activity as well as a direct effect on the hepatic fatty acid synthesizing system. A stimulator of hepatic fatty acid synthesis is present in the buffer insoluble fraction of an acetone powder preparation of renal microsomes. This stimulator is relatively heat labile and does not appear to be a phospholipid. The lysosomal stimulator of hepatic fatty acid synthesis is associated with the contents of renal lysosomes and not with the lysosomal membranes. It acts at the acetyl-CoA carboxylase step and its activity is not affected by fasting or aminonucleoside induced nephrosis.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D003067:Coenzymes / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D003864:Depression, Chemical; D005227:Fatty Acids / Q000096:biosynthesis*; D066298:In Vitro Techniques; D007668:Kidney / Q000648:ultrastructure*; D008099:Liver / Q000378:metabolism*; D008247:Lysosomes / Q000378:metabolism*; D008297:Male; D008861:Microsomes / Q000378:metabolism*; D009402:Nephrosis, Lipoid / Q000378:metabolism; D011402:Pronase / Q000494:pharmacology; D051381:Rats; D013347:Subcellular Fractions / Q000378:metabolism
D003067:Coenzymes; D005227:Fatty Acids; D000255:Adenosine Triphosphate; D011402:Pronase